trending Market Intelligence /marketintelligence/en/news-insights/trending/xmnvjjpfh4l22oisj9lxvq2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Vaxil appoints CEO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Vaxil appoints CEO

Israel-based Vaxil Bio Ltd. appointed David Goren CEO and board member.

Goren previously held senior positions at drugmakers Pfizer Inc. and AstraZeneca PLC.

Vaxil develops and sells immunotherapies for cancer and other diseases in Israel.